GRI Bio Inc.
GRI | NASDAQ
$1.92
-$0.01 (-0.52%)
Sep 21, 2026, 11:16 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 100K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -11.98M | -8.24M | -11.39M | -2.24M | -1.06M | -1.46M |
Interest Income | 21K | 25K | n/a | n/a | n/a | n/a |
Pretax Income | -11.96M | -8.21M | -13.04M | -3.22M | -1.56M | -2.53M |
Net Income | -11.96M | -8.21M | -13.04M | -3.22M | -1.56M | -2.53M |
Selling & General & Admin | 5.16M | 4.47M | 8.16M | 2M | 813K | 1.2M |
Research & Development | 6.82M | 3.77M | 3.23M | 242K | 249K | 264K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 11.98M | 8.24M | 11.39M | 2.24M | 1.06M | 1.46M |
Interest Expense | n/a | n/a | 2.08M | 653K | 547K | 34K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.98M | 8.24M | 11.39M | 2.24M | 1.06M | 1.46M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 98.16K | 4.9M | 1.58K | 1.16K | 11.6K | 891 |
Shares Outstanding (Diluted) | 98.16K | 4.92M | 1.58K | 1.16K | 11.6K | 891 |
EPS (Basic) | -121.80 | 0.33 | -140.45K | -47.14K | -2.83K | -4.69K |
EPS (Diluted) | -121.80 | 0.33 | -140.45K | -47.14K | -2.83K | -4.69K |
EBITDA | -11.97M | -8.23M | -10.95M | -2.56M | -1.06M | -1.46M |
EBIT | -11.98M | -8.24M | -10.96M | -2.56M | -1.06M | -1.46M |
Depreciation & Amortization | 4K | 4K | 4K | 3K | 3K | 3K |
Add to Watchlist
Select watchlists to add or remove GRI